Gene · 2248
Papers2,103
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
861 to 880 of 2,103
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A mutation-specific, single-arm, phase 2 study of dovitinib in patients with advanced malignancies. | Oncotarget | 2020 | 32292573 | PubTator, text mining | PubMed |
| Production of Human Pluripotent Stem Cell-Derived Hepatic Cell Lineages and Liver Organoids: Current Status and Potential Applications. | Bioengineering (Basel) | 2020 | 32283585 | PubTator, text mining | PubMed |
| Cardiac interventions in patients with achondroplasia: a systematic review. | J Thorac Dis | 2020 | 32274169 | PubTator, text mining | PubMed |
| Comprehensive genomic profile of cholangiocarcinomas in China. | Oncol Lett | 2020 | 32256810 | PubTator, text mining | PubMed |
| Mechanisms of larynx and vocal fold development and pathogenesis. | Cell Mol Life Sci | 2020 | 32253462 | PubTator, text mining | PubMed |
| Landscape of copy number aberrations in esophageal squamous cell carcinoma from a high endemic region of South Africa. | BMC Cancer | 2020 | 32252688 | PubTator, text mining | PubMed |
| Association between craniofacial morphological patterns and tooth agenesis-related genes. | Prog Orthod | 2020 | 32249341 | PubTator, text mining | PubMed |
| Prognostic Value of TP53 Mutation for Transcatheter Arterial Chemoembolization Failure/Refractoriness in HBV-Related Advanced Hepatocellular Carcinoma. | Cancer Res Treat | 2020 | 32229792 | PubTator, text mining | PubMed |
| High-risk human papillomavirus-mediated adenocarcinoma of palatine tonsil. | Pathol Res Pract | 2020 | 32224073 | PubTator, text mining | PubMed |
Molecular Analysis of Selected Resistance Determinants in Diarrheal Fecal Samples Collected From Kolkata, India Reveals an Abundance of Resistance Genes and the Potential Role of the Microbiota in Its Dissemination. | Front Public Health | 2020 | 32219088 | PubTator, text mining | PubMed |
| The Na,K-ATPase acts upstream of phosphoinositide PI(4,5)P2 facilitating unconventional secretion of Fibroblast Growth Factor 2. | Commun Biol | 2020 | 32214225 | PubTator, text mining | PubMed |
| The Role of Fibroblast Growth Factor 10 Signaling in Duodenal Atresia. | Front Pharmacol | 2020 | 32210824 | PubTator, text mining | PubMed |
| Breast Cancer: A Molecularly Heterogenous Disease Needing Subtype-Specific Treatments. | Med Sci (Basel) | 2020 | 32210163 | PubTator, text mining | PubMed |
| Infigratinib in upper tract urothelial carcinoma versus urothelial carcinoma of the bladder and its association with comprehensive genomic profiling and/or cell-free DNA results. | Cancer | 2020 | 32208524 | PubTator, text mining | PubMed |
| Synthesis of Cross-Conjugated Polyenes via Palladium-Catalyzed Oxidative C-C Bond Forming Cascade Reactions of Allenes. | J Org Chem | 2020 | 32207975 | PubTator, text mining | PubMed |
| Tumor mutation burden derived from small next generation sequencing targeted gene panel as an initial screening method. | Transl Lung Cancer Res | 2020 | 32206555 | PubTator, text mining | PubMed |
| Generation of Otic Lineages from Integration-Free Human-Induced Pluripotent Stem Cells Reprogrammed by mRNAs. | Stem Cells Int | 2020 | 32190057 | PubTator, text mining | PubMed |
| A Comparative Analysis of Tumors and Plasma Circulating Tumor DNA in 145 Advanced Cancer Patients Annotated by 3 Core Cellular Processes. | Cancers (Basel) | 2020 | 32188081 | PubTator, text mining | PubMed |
| An Improved PIII/PV═O-Catalyzed Reductive C-N Coupling of Nitroaromatics and Boronic Acids by Mechanistic Differentiation of Rate- and Product-Determining Steps. | J Am Chem Soc | 2020 | 32178514 | PubTator, text mining | PubMed |
| Engineering PEG-based hydrogels to foster efficient endothelial network formation in free-swelling and confined microenvironments. | Biomaterials | 2020 | 32172030 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2248/papers?page=44